109 related articles for article (PubMed ID: 1845955)
1. Increased glutathione peroxidase activity in a human sarcoma cell line with inherent doxorubicin resistance.
Samuels BL; Murray JL; Cohen MB; Safa AR; Sinha BK; Townsend AJ; Beckett MA; Weichselbaum RR
Cancer Res; 1991 Jan; 51(2):521-7. PubMed ID: 1845955
[TBL] [Abstract][Full Text] [Related]
2. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin.
Lau DH; Lewis AD; Ehsan MN; Sikic BI
Cancer Res; 1991 Oct; 51(19):5181-7. PubMed ID: 1717140
[TBL] [Abstract][Full Text] [Related]
3. Adriamycin activation and oxygen free radical formation in human breast tumor cells: protective role of glutathione peroxidase in adriamycin resistance.
Sinha BK; Mimnaugh EG; Rajagopalan S; Myers CE
Cancer Res; 1989 Jul; 49(14):3844-8. PubMed ID: 2544260
[TBL] [Abstract][Full Text] [Related]
4. P-glycoprotein-independent mechanism of resistance to VP-16 in multidrug-resistant tumor cell lines: pharmacokinetic and photoaffinity labeling studies.
Politi PM; Arnold ST; Felsted RL; Sinha BK
Mol Pharmacol; 1990 Jun; 37(6):790-6. PubMed ID: 1972771
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of doxorubicin cytotoxicity by buthionine sulfoximine in multidrug-resistant human breast tumor cells.
Dusre L; Mimnaugh EG; Myers CE; Sinha BK
Cancer Res; 1989 Feb; 49(3):511-5. PubMed ID: 2535960
[TBL] [Abstract][Full Text] [Related]
6. Alterations in glutathione and glutathione-related enzymes in a multidrug-resistant small cell lung cancer cell line.
Cole SP; Downes HF; Mirski SE; Clements DJ
Mol Pharmacol; 1990 Feb; 37(2):192-7. PubMed ID: 1968221
[TBL] [Abstract][Full Text] [Related]
7. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC
Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143
[TBL] [Abstract][Full Text] [Related]
8. Modulation of multidrug resistance p-glycoprotein activity by flavonoids and honokiol in human doxorubicin- resistant sarcoma cells (MES-SA/DX-5): implications for natural sedatives as chemosensitizing agents in cancer therapy.
Angelini A; Di Ilio C; Castellani ML; Conti P; Cuccurullo F
J Biol Regul Homeost Agents; 2010; 24(2):197-205. PubMed ID: 20487633
[TBL] [Abstract][Full Text] [Related]
9. Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA.
Harker WG; Sikic BI
Cancer Res; 1985 Sep; 45(9):4091-6. PubMed ID: 4028002
[TBL] [Abstract][Full Text] [Related]
10. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
Deffie AM; Alam T; Seneviratne C; Beenken SW; Batra JK; Shea TC; Henner WD; Goldenberg GJ
Cancer Res; 1988 Jul; 48(13):3595-602. PubMed ID: 2897875
[TBL] [Abstract][Full Text] [Related]
11. Antioxidant and xenobiotic-metabolizing enzyme gene expression in doxorubicin-resistant MCF-7 breast cancer cells.
Akman SA; Forrest G; Chu FF; Esworthy RS; Doroshow JH
Cancer Res; 1990 Mar; 50(5):1397-402. PubMed ID: 2406012
[TBL] [Abstract][Full Text] [Related]
12. Differential oxygen radical susceptibility of adriamycin-sensitive and -resistant MCF-7 human breast tumor cells.
Mimnaugh EG; Dusre L; Atwell J; Myers CE
Cancer Res; 1989 Jan; 49(1):8-15. PubMed ID: 2535695
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines.
Slovak ML; Hoeltge GA; Dalton WS; Trent JM
Cancer Res; 1988 May; 48(10):2793-7. PubMed ID: 2896069
[TBL] [Abstract][Full Text] [Related]
14. In vitro multidrug resistance of P388 murine leukemia selected for resistance to diaziquone.
Gutierrez PL; Wilder PJ; Biswal N
Cancer Commun; 1989; 1(3):181-90. PubMed ID: 2576972
[TBL] [Abstract][Full Text] [Related]
15. Stable differentiation of a human colon adenocarcinoma cell line by sodium butyrate is associated with multidrug resistance.
Ho SB; Yan PS; Dahiya R; Neuschwander-Tetri BA; Basbaum C; Kim YS
J Cell Physiol; 1994 Aug; 160(2):213-26. PubMed ID: 7913708
[TBL] [Abstract][Full Text] [Related]
16. Verapamil reversal of doxorubicin resistance in multidrug-resistant human myeloma cells and association with drug accumulation and DNA damage.
Bellamy WT; Dalton WS; Kailey JM; Gleason MC; McCloskey TM; Dorr RT; Alberts DS
Cancer Res; 1988 Nov; 48(22):6365-70. PubMed ID: 3180056
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of resistance to ansamycin antibiotics in human breast cancer cell lines.
Benchekroun MN; Schneider E; Safa AR; Townsend AJ; Sinha BK
Mol Pharmacol; 1994 Oct; 46(4):677-84. PubMed ID: 7969046
[TBL] [Abstract][Full Text] [Related]
18. Biochemical characterization of resistance to mitoxantrone and adriamycin in Caco-2 human colon adenocarcinoma cells: a possible role for glutathione S-transferases.
Peters WH; Roelofs HM
Cancer Res; 1992 Apr; 52(7):1886-90. PubMed ID: 1348015
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the antioxidant activities in dox-sensitive and -resistant Friend leukemia cells. Effect of doxorubicin.
Crescimanno M; D'Alessandro N; Armata MG; Toulmond S; Tapiero H
Anticancer Res; 1991; 11(2):901-3. PubMed ID: 2064348
[TBL] [Abstract][Full Text] [Related]
20. Verapamil-mediated sensitization of doxorubicin-selected pleiotropic resistance in human sarcoma cells: selectivity for drugs which produce DNA scission.
Harker WG; Bauer D; Etiz BB; Newman RA; Sikic BI
Cancer Res; 1986 May; 46(5):2369-73. PubMed ID: 3754487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]